Biote reports third quarter 2025 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the third quarter ended september 30, 2025. “when we undertook our organizational restructuring in may, we identified three strategic priorities: accelerate growth from new providers, maximize value from our top-tier clinics, and improve our financial performance through gre.
BTMD Ratings Summary
BTMD Quant Ranking